Skip to content

Evaluation on Efficacy and Safety of Maintenance Treatment with Traditional Chinese Medicine in Advanced Non-Small-Cell Lung Cancer

Evaluation on Efficacy and Safety of Maintenance Treatment with Traditional Chinese Medicine in Advanced Non-Small-Cell Lung Cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OOC-16009671
Enrollment
Unknown
Registered
2016-10-26
Start date
2016-03-22
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-Small-Cell Lung Cancer

Interventions

Western Medicine Maintainence Treatment:therapeutic plan NCCN guidelines recommend
TCM Maintainence Treatment:Comprehensive TCM treatment plan
Western Medicine & TCM Treatment:Comprehensive TCM treatment plan& therapeutic plan NCCN guidelines recommend

Sponsors

Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) diagnosed by pathology or cytology initial treatment III - IV NSCLC patients with tumor; (2) after 2-4 chemotherapy cycles,evaluated SD above,entering maintainence phase,within one month after the chemotherapy ends; (3) ECOG score: 0-3, KPS score:=50; (4) expected survive period = 3 months; (5) aged from 18 to 75 years; (6) signed informed consent, good adherence.

Exclusion criteria

Exclusion criteria: (1) patients without pathological or cytological diagnosis of NSCLC; (2) women during pregnancy or lactation, psychiatric patients; (3) patients with severe uncontrolled organic disease or infection, such as decompensated heart, lung, kidney failure etc. that can't tolerate chemotherapy; (4) patients in other clinical trials; (5) patients allergic to study drug; (6) patinets with history of using targeted drug.

Design outcomes

Primary

MeasureTime frame
Progression-Free-Survival (PFS);

Secondary

MeasureTime frame
Overall Survival (OS);Quality of Life (QoL);Disease Control Rate (DCR);TCM syndrome curative effect;

Countries

China

Contacts

Public ContactWei Hou

Guang'anmen Hospital, China Academy of Chinese Medical Sciences

houwei1964@163.com+86 13701361625

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026